Skip to content

About
Clinical Trials
Training
KRN-101
Investing
Contact

Menu

About
Clinical Trials
Training
KRN-101
Investing
Contact

CSE: ABRT • FSE: VB50

About
Clinical Trials
Training
KRN-101
Investing
Contact

Menu

About
Clinical Trials
Training
KRN-101
Investing
Contact

CSE: ABRT • FSE: VB50

Contact Us

Accelerating access to innovative mental health medicines for patients with urgent and unmet needs.

I would like to receive email updates and general information about Albert Labs.

Canada

+1 778-819-0740
6996, Merritt Ave, Burnaby, BC, V5J 4R6

United Kingdom

+44 1625 324 960
61 Mosley Street, Manchester, M2 3HZ

Portugal

+44 1625 324 960
Rua Central de Gandra, 4585-116 Porto

Innovative mental health medicines for patients with unmet needs

Legal Disclaimer
Privacy Policy
Modern Slavery Statement
Cookie Policy

Legal Disclaimer
Privacy Policy
Modern Slavery Statement
Cookie Policy

© 2024 Albert Labs. All Rights Reserved

About
Clinical Trials
Training
KRN-101
Investing
Contact

About
Clinical Trials
Training
KRN-101
Investing
Contact

Twitter Linkedin Youtube Envelope

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

Name*
First Last
Email*
Phone
Comments
This field is for validation purposes and should be left unchanged.

76599

Latest Press Release

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

Name*
First
Phone*

72650